Potential bioavailability enhancement of bioactive compounds using food-grade engineered nanomaterials: a review of the existing evidence

Abstract

The development of engineered nanometre sized materials (ENM) produced with food-grade ingredients and designed as delivery systems for organic and inorganic materials has gained increasing interest. The major reason for this trend is the aim to overcome problems associated with the low bioavailability of many bioactive compounds (BC) which are usually claimed to benefit human health. In this review, outcomes of studies investigating the potential bioavailability enhancement of BC using ENM as delivery systems are summarised and discussed. It focuses on in vitro and in vivo studies carried out with ENM produced with food-grade materials and designed for the delivery of vitamins, other secondary plant metabolites and minerals. Furthermore, the physical and physicochemical aspects governing the preparation of the systems, the loading of the BC, the stability of the delivery systems in food applications and finally the release of the BC in the gastrointestinal tract are also considered. The mechanisms leading to an enhanced bioavailability are based on (i) improved solubility of the BC under gastrointestinal conditions, (ii) the protection of the BC from the chemical conditions in the gastrointestinal tract (GIT), (iii) the controlled release within the GIT or (iv) an improved transfer through the intestinal wall. The main outcome of the review is that particle size, surface properties and physical state of the ENM are key parameters to be controlled aiming at an enhanced nutritional value of food materials. Furthermore, the bioavailability classification scheme (BCS) can help to understand the efficacy of different ENM for the delivery of specific BC.

Exosomal formulation of anthocyanidins against multiple cancer types

“…Many plant bioactives suffer from notoriously poor bioavailability and instability [1–4] and therefore have failed to shine their full potential despite high doses. Several strategies have been investigated in order to achieve clinical efficacy of drugs with poor bioavailability and stability.…”

In Vitro Bioaccessibility of Low‐Crystallinity Phytosterol Nanoparticles Generated Using Nanoporous Starch Bioaerogels

“…Zeta potential values were in good agreement with our data of phytosterol particle stability in the micellar phase (Figure ). It is well known that as zeta potential decreases, the electrostatic repulsion between particles decreases which leads to aggregation (Oehlke et al., ; Tangsrianugul et al., ). Therefore, the relatively low zeta potential of the PS‐NSA physical mixture resulted in the precipitation of crude phytosterols during centrifugation.…”

The Preventive Approach of Biocompounactives (2): A Review in Recent Advances in Common Fruits

“…The mechanisms leading to better bioavailability, according to the authors, are based on (i) improved solubility of the bioactive compounds in gastrointestinal conditions, (ii) protection of bioactive compounds from chemical conditions in the gastrointestinal tract, (iii) controlled release in the gastrointestinal tract, or (iv) improved transfer through the intestinal wall [370].…”